A multicentre retrospective analysis of recurrent/metastatic (RM) nasopharyngeal cancer (NPC) from non-endemic areas: Results in the pre-immunotherapy era

被引:0
|
作者
Bossi, P. [1 ]
Alberti, A. [1 ]
Zamparini, M. [1 ]
Orlandi, E. [2 ]
Grisanti, S. [1 ]
Trama, A. [3 ]
Resteghini, C. [4 ]
Nin, R. Mesia [5 ]
Mohamad, I. [6 ]
Ozyar, E. [7 ]
Buglione, M. [8 ]
Airoldi, M. [9 ]
Vecchio, S. [10 ]
Livi, L. [11 ]
Cirauqui, B. Cirauqui [12 ]
El-Sherify, M. [13 ]
Ursino, S. [14 ]
Argiris, A. [15 ]
Galiana, I. Linares [16 ]
Licitra, L. F. [4 ]
机构
[1] Univ Brescia, ASST Spedali Civili, Med Oncol Unit, Dept Med & Surg Specialties Radiol Sci & Publ Hlt, Brescia, Italy
[2] Ctr Nazl Adroterapia Oncol CNAO, Clin Dept, Pavia, Italy
[3] Fdn IRCCS Ist Nazl Tumori, Dept Res, Evalutat Epidemiol Unit, Milan, Italy
[4] Fdn IRCCS Ist Nazl Tumori, Head & Neck Med Oncol Unit, Milan, Italy
[5] Hosp Duran & Reynals, ICO Inst Catala Oncol, Med Oncol Dept, Lhospitalet De Llobregat, Spain
[6] KHCC King Hussein Canc Ctr, Dept Radiat Oncol, Amman, Jordan
[7] Acibadem Mehmet Ali Aydinlar Univ, Radiat Oncol, Istanbul, Turkey
[8] Univ Brescia, ASST Spedali Civili, Dept Med & Surg Specialties Radiol Sci & Publ Hlt, Radiat Oncol Unit, Brescia, Italy
[9] AOU Citta Salute Sci Torino, Med Oncol Div 2, Turin, Italy
[10] IST Ist Nazl Ric Cancro, IRCCS AOU San Martino, Oncol, Genoa, Italy
[11] Azienda Osped Univ Careggi, Oncol Dept, Radiat Oncol Unit, Florence, Italy
[12] Hosp Badalona Germans Trias & Pujol, ICO Inst Catala Oncol Badalona, Med Oncol Dept, Barcelona, Spain
[13] Damitta Oncol Ctr, Clin Oncol Dept, Dumyat, Egypt
[14] AOU Pisana Stabilimento Santa Chiara, Dept Radiat Oncol, Pisa, Italy
[15] Hygeia Hosp, Med Oncol Dept, Maroussi, Greece
[16] Hosp Univ Virgen Nieves, Dept Radiat Oncol, Granada, Spain
关键词
D O I
10.1016/j.annonc.2022.07.788
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
664P
引用
收藏
页码:S846 / S846
页数:1
相关论文
共 12 条
  • [1] Nasopharyngeal cancer in non-endemic areas: Impact of treatment intensity within a large retrospective multicentre cohort
    Bossi, Paolo
    Trama, Annalisa
    Bernasconi, Alice
    Grisanti, Salvatore
    Mohamad, Issa
    Galiana, Isabel L.
    Ozyar, Enis
    Franco, Pierfrancesco
    Vecchio, Stefania
    Bonomo, Pierluigi
    Cirauqui, Beatriz C.
    El-Sherify, Mustafa
    Ursino, Stefano
    Argiris, Athanassios
    Pan, Jonathan
    Wittekindt, Claus
    D'Angelo, Elisa
    Costa, Loredana
    Buglione, Michela
    Johnson, Jennifer
    Airoldi, Mario
    Mesia, Ricard
    Resteghini, Carlo
    Licitra, Lisa
    Orlandi, Ester
    EUROPEAN JOURNAL OF CANCER, 2021, 159 : 194 - 204
  • [2] Long-term outcomes and toxicity of treatment for nasopharyngeal carcinoma in the modern era: Results from a single institute in a non-endemic area
    Yee, D
    Hanson, J
    Lau, H
    Siever, J
    Gluck, S
    RADIOTHERAPY AND ONCOLOGY, 2005, 76 : S41 - S41
  • [3] Real-world treatment patterns and survival outcomes for advanced non-small cell lung cancer in the pre-immunotherapy era in Portugal: a retrospective analysis from the I-O Optimise initiative
    Marta Soares
    Luís Antunes
    Patrícia Redondo
    Marina Borges
    Ruben Hermans
    Dony Patel
    Fiona Grimson
    Robin Munro
    Carlos Chaib
    Laure Lacoin
    Melinda Daumont
    John R. Penrod
    John C. O’Donnell
    Maria José Bento
    Francisco Rocha Gonçalves
    BMC Pulmonary Medicine, 20
  • [4] Real-world treatment patterns and survival outcomes for advanced non-small cell lung cancer in the pre-immunotherapy era in Portugal: a retrospective analysis from the I-O Optimise initiative
    Soares, Marta
    Antunes, Luis
    Redondo, Patricia
    Borges, Marina
    Hermans, Ruben
    Patel, Dony
    Grimson, Fiona
    Munro, Robin
    Chaib, Carlos
    Lacoin, Laure
    Daumont, Melinda
    Penrod, John R.
    O'Donnell, John C.
    Bento, Maria Jose
    Rocha Goncalves, Francisco
    BMC PULMONARY MEDICINE, 2020, 20 (01)
  • [5] Validation of the 8th Edition of the UICC/AJCC Staging System for Nasopharyngeal Carcinoma From non-Endemic Areas in the Era of Intensity-Modulated Radiation Therapy
    Lang, J.
    Lan, M.
    Feng, M.
    Xu, P.
    Fu, B.
    Duan, Z.
    Zhang, S.
    Qin, Y.
    Peng, X.
    Liu, J.
    Li, F.
    Lu, S.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2018, 102 (03): : E276 - E277
  • [6] High prevalence of malaria in a non-endemic setting among febrile episodes in travellers and migrants coming from endemic areas: a retrospective analysis of a 2013–2018 cohort
    Alejandro Garcia-Ruiz de Morales
    Covadonga Morcate
    Elena Isaba-Ares
    Ramon Perez-Tanoira
    Jose A. Perez-Molina
    Malaria Journal, 20
  • [7] High prevalence of malaria in a non-endemic setting among febrile episodes in travellers and migrants coming from endemic areas: a retrospective analysis of a 2013-2018 cohort
    Garcia-Ruiz De Morales, Alejandro
    Morcate, Covadonga
    Isaba-Ares, Elena
    Perez-Tanoira, Ramon
    Perez-Molina, Jose A.
    MALARIA JOURNAL, 2021, 20 (01)
  • [8] Long-term outcomes of operable stage III NSCLC in the pre-immunotherapy era: results from a pooled analysis of the SAKK 16/96, SAKK 16/00, SAKK 16/01, and SAKK 16/08 trials
    Koenig, D.
    Schaer, S.
    Vuong, D.
    Guckenberger, M.
    Furrer, K.
    Opitz, I
    Weder, W.
    Rothschild, S., I
    Ochsenbein, A.
    Zippelius, A.
    Addeo, A.
    Mark, M.
    Eboulet, E., I
    Hayoz, S.
    Thierstein, S.
    Betticher, D. C.
    Ris, H-B
    Stupp, R.
    Curioni-Fontecedro, A.
    Peters, S.
    Pless, M.
    Frueh, M.
    ESMO OPEN, 2022, 7 (02)
  • [9] Long-term outcomes of operable stage III NSCLC in the pre-immunotherapy era: results from a pooled analysis of the SAKK 16/96, SAKK 16/00, SAKK 16/01, and SAKK 16/08 trials (vol 7, 100455, 2022)
    Konig, D.
    Schar, S.
    Vuong, D.
    Guckenberger, M.
    Furrer, K.
    Opitz, I.
    Weder, W.
    Rothschild, S. I.
    Ochsenbein, A.
    Zippelius, A.
    Addeo, A.
    Mark, M.
    Eboulet, E. I.
    Hayoz, S.
    Thierstein, S.
    Betticher, D. C.
    Ris, H. -B.
    Stupp, R.
    Curioni-Fontecedro, A.
    Peters, S.
    Pless, M.
    Fruh, M.
    ESMO OPEN, 2022, 7 (03)
  • [10] Which Patients with advanced/metastatic non-small cell Lung Cancer benefit from combined Chema-immunotherapy in the First-line Treatment? A retrospective, monocentric Analysis
    Mamot, M.
    Wallrabenstein, T.
    Daetwyler, E.
    Konig, D.
    Rothschild, S. I.
    ONCOLOGY RESEARCH AND TREATMENT, 2022, 45 (SUPPL 2) : 100 - 100